Home/Filings/4/0001209191-21-006790
4//SEC Filing

Brewis Neil 4

Accession 0001209191-21-006790

CIK 0001566373other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:29 PM ET

Size

5.3 KB

Accession

0001209191-21-006790

Insider Transaction Report

Form 4
Period: 2021-02-01
Brewis Neil
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2021-02-01+18,00037,844 total
Footnotes (2)
  • [F1]The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the shares shall vest on the one-year anniversary of the date of the grant, and thereafter shall vest in equal monthly installments over the remaining three years.
  • [F2]Includes 18,000 RSUs.

Issuer

F-star Therapeutics, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001831247

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:29 PM ET
Size
5.3 KB